Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

TNFSF14 anticorps (AA 51-239)

TNFSF14 Reactivité: Souris WB, IHC, IP, ICC Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN1173716
  • Antigène Voir toutes TNFSF14 Anticorps
    TNFSF14 (Tumor Necrosis Factor (Ligand) Superfamily, Member 14 (TNFSF14))
    Épitope
    • 16
    • 8
    • 6
    • 6
    • 6
    • 5
    • 4
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 51-239
    Reactivité
    • 57
    • 31
    • 23
    • 5
    • 4
    • 4
    • 1
    • 1
    Souris
    Hôte
    • 66
    • 15
    • 1
    Lapin
    Clonalité
    • 68
    • 14
    Polyclonal
    Conjugué
    • 28
    • 11
    • 9
    • 6
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp TNFSF14 est non-conjugé
    Application
    • 60
    • 31
    • 27
    • 13
    • 13
    • 12
    • 7
    • 6
    • 5
    • 5
    • 3
    • 3
    • 2
    Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
    Fonction
    Polyclonal Antibody to Tumor Necrosis Factor Ligand Superfamily, Member 14 (TNFSF14)
    Specificité
    The antibody is a rabbit polyclonal antibody raised against TNFSF14. It has been selected for its ability to recognize TNFSF14 in immunohistochemical staining and western blotting.
     Réactivité croisée
    Rat
    Purification
    Antigen-specific affinity chromatography followed by Protein A affinity chromatography
    Immunogène
    Recombinant Tumor Necrosis Factor Ligand Superfamily, Member 14 (TNFSF14) corresdonding to Thr51~Val239 with N-terminal His Tag
    Isotype
    IgG
    Top Product
    Discover our top product TNFSF14 Anticorps primaire
  • Indications d'application

    Western blotting: 0.5-2 μg/mL Immunohistochemistry: 5-20 μg/mL Immunocytochemistry: 5-20 μg/mL Optimal working dilutions must be determined by end user.

    Commentaires

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    Lot specific
    Buffer
    0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol.
    Agent conservateur
    ProClin
    Précaution d'utilisation
    WARNING: Reagents contain sodium azide. Sodium azide is very toxic if ingested or inhaled. Avoid contact with skin, eyes, or clothing. Wear eye or face protection when handling. If skin or eye contact occurs, wash with copious amounts of water. If ingested or inhaled, contact a physician immediately. Sodium azide yields toxic hydrazoic acid under acidic conditions. Dilute azide-containing compounds in running water before discarding to avoid accumulation of potentially explosive deposits in lead or copper plumbing.
    Conseil sur la manipulation
    Avoid repeated freeze-thaw cycles.
    Stock
    4 °C,-20 °C
    Stockage commentaire
    Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
    Date de péremption
    24 months
  • Antigène
    TNFSF14 (Tumor Necrosis Factor (Ligand) Superfamily, Member 14 (TNFSF14))
    Autre désignation
    Tumor Necrosis Factor Ligand Superfamily, Member 14 (TNFSF14 Produits)
    Synonymes
    anticorps TNFSF14, anticorps CD258, anticorps HVEML, anticorps LIGHT, anticorps LTg, anticorps TR2, anticorps HVEM-L, anticorps Ly113, anticorps TNF superfamily member 14, anticorps tumor necrosis factor (ligand) superfamily, member 14, anticorps TNFSF14, anticorps Tnfsf14
    Sujet
    CD258, TR2, HVEML, LIGHT, LTg, Herpes virus entry mediator ligand, Herpesvirus entry mediator ligand
    Pathways
    Cancer Immune Checkpoints
Vous êtes ici:
Support technique